99% CAS 849217-48-7 Cabozantinib API XL186 Cabozantinib Pharmaceutical Cabozantinib
Product Description
Product Details
Product Name |
Cabozantinib |
Appearance |
White Crystalline Powder |
CAS No |
849217-48-7 |
MF |
C28H24FN3O5 |
Cabozantinib is used for medullary thyroid carcinoma. And advanced renal cell carcinoma in people who have previously received anti-angiogenic therapy. Currently, it is undergoing clinical trials to treat prostate cancer, bladder cancer, ovarian cancer, brain cancer, melanoma, breast cancer, non-small cell lung cancer, pancreatic cancer and hepatocellular carcinoma.
Application&Function
Cabozantinib is used for medullary thyroid carcinoma. And advanced renal cell carcinoma in people who have previously received anti-angiogenic therapy. Currently, it is undergoing clinical trials to treat prostate cancer, bladder cancer, ovarian cancer, brain cancer, melanoma, breast cancer, non-small cell lung cancer, pancreatic cancer and hepatocellular carcinoma.
Specification